Custom Search


Portfolio of Gene Editing Stocks

Here are 4 gene editing stocks.

Portfolio of Gene Editing Stocks
Stock
Price Quote & Dividend
1-Yr Price Chart
Crispr Therapeutics
Editas Medicine
Intellia Therapeutics 
Sangamo Therapeutics 
Price data from Quandl.


To inspect the performance of the Portfolio of Gene Editing Stocks portfolio, see the returns table and chart below. Portfolio values are computed using monthly closes for from Quandl.

All 4 are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each at its closing weekly price for the current date in 2017.






Related Articles

Portfolio of Biotech Stocks: Cancer
Portfolio of Gene Editing (CRISPR) Stocks
Portfolio of Gene Sequencing Stocks
Portfolio of Gene Therapy Stocks
Portfolio of Genetic Testing Stocks
Portfolio of Genomics Stocks
Portfolio of Personalized Medicine Stocks
Portfolio of Stem Cell Stocks
Portfolio of Synthetic Biology Stocks